Recap: Treating Patients With HER2+ Metastatic Breast Cancer: Insights From Experts at Dana- Farber Cancer Institute
Based on several patient cases, expert oncologists review the evolving treatment landscape of HER2+ breast cancer with a focus on brain metastases.
Recap: Mayo and Moffitt Face-Off in Myeloma Data Presentation
Experts from the Mayo Clinic and Moffitt Cancer Center go head-to-head to discuss recent data in multiple myeloma and updates from recent meetings.
Recap: Real-world Application of Updated Breast Cancer Results
Experts discuss updates in HR+ breast cancer, with a focus on treatment options before and after progression and emerging data.
Recap: HER2+ Breast Cancer and Brain Metastases: Challenges and Treatments
Breast cancer experts discuss the latest research into the treatment of HER2+ metastatic breast cancer with brain metastases and how new data may affect decision-making in 3 patient cases.
Recap: Experts Review Tagraxofusp and Long-term Benefits in Blastic Plasmacytoid Dendritic Cell Neoplasm
Expert hematologist-oncologists review the clinical data on the long-term use of tagraxofusp and share their real-world experiences.
2 Commerce Drive Cranbury, NJ 08512